Endocrine Deep Dives podcast artwork
Education

Endocrine Deep Dives

by Gurbir Gill, MD
Share this ranking Claiming needs an RSS feed. Contact us.

Chart positions today · Canada

Not on the Canada charts we track today.

If you like Endocrine Deep Dives, try…

Latest episodes

  • Teprotumumab

    October 8, 2026 · 22 min

    Teprotumumab is a fully human monoclonal antibody targeting the insulin-like growth factor 1 receptor, revolutionizing the medical management of active thyroid eye disease. By blocking receptor signaling on orbital fibroblasts, it reduces…

  • Fragile X Premutation

    October 7, 2026 · 21 min

    Fragile X premutation carriers harbor FMR1 allele expansions containing fifty-five to two hundred CGG repeats, predisposing them to distinct clinical syndromes driven by elevated toxic messenger ribonucleic acid levels. Adult carriers face…

  • Bone Turnover Markers

    October 6, 2026 · 23 min

    PODCAST SUMMARY: Bone turnover markers provide dynamic, real-time biochemical assessment of skeletal metabolism by quantifying bone formation through serum osteocalcin and procollagen type 1 N-terminal propeptide alongside bone resorption…

  • Hyperparathyroidism: Surgery vs Bisphosphonates Timing

    October 5, 2026 · 23 min

    Primary hyperparathyroidism management hinges on distinguishing symptomatic from asymptomatic disease and assessing surgical candidacy according to established biochemical and densitometric thresholds. Parathyroidectomy remains the only…

  • Persistent Post Thyroidectomy Tingling Despite Normocalcemia

    October 2, 2026 · 27 min

    Post thyroidectomy hypocalcemia typically presents with perioral tingling and neuromuscular irritability driven by transient or permanent hypoparathyroidism. Early clinical identification relies on eliciting Chvostek and Trousseau signs…

Show 7 more episodesShow fewer episodes
  • Real world use of Palopegteriparatide

    October 1, 2026 · 19 min

    A long-acting parathyroid hormone prodrug engineered for continuous parathyroid hormone receptor type 1 activation via physiologic autocleavage. Once-daily administration maintains stable serum calcium and phosphate levels while lowering…

  • Everything About Palopegteriparatide

    September 30, 2026 · 17 min

    Palopegteriparatide is a long-acting prodrug of parathyroid hormone designed for once-weekly subcutaneous administration in hypoparathyroidism. By providing sustained physiological systemic exposure, it normalizes serum calcium and urinary…

  • Levothyroxine Interactions and More and More

    September 29, 2026 · 23 min

    Levothyroxine absorption is highly vulnerable to gastrointestinal disruptions and concurrent ingestions. Common culprits include calcium carbonate, ferrous sulfate, proton pump inhibitors, and fiber supplements, which bind the hormone or…

  • Hunt for the Elusive Neuropeptides

    September 28, 2026 · 26 min

    The intense rivalry between Roger Guillemin and Andrew Schally revolutionized neuroendocrinology through the isolation of hypothalamic releasing hormones. Following their initial collaboration at Baylor University, the two researchers…

  • IPSS Case Studies

    September 25, 2026 · 26 min

    Inferior petrosal sinus sampling differentiates Cushing disease from ectopic adrenocorticotropic hormone secretion using simultaneous petrosal and peripheral venous hormone measurements. A normal pituitary magnetic resonance imaging does…

  • Inferior petrosal sinus sampling

    September 24, 2026 · 23 min

    Inferior petrosal sinus sampling is the diagnostic gold standard for localizing the source of adrenocorticotropic hormone dependent Cushing syndrome when pituitary imaging is non diagnostic or discordant. The procedure relies on comparing…

  • Testing for 1-25 dihydroxy Vitamin D

    September 23, 2026 · 26 min

    Assessing nutritional vitamin D status requires measuring 25-hydroxyvitamin D, as serum 1,25-dihydroxyvitamin D is tightly regulated by parathyroid hormone, calcium, and phosphate, often remaining normal or paradoxically elevated in severe…

Full episode archive on Apple Podcasts →

About the show

The Endocrine Deep Dive covers advanced topics in endocrinology. Utilizing AI-driven synthetic audio discussions from my own study notes, each episode breaks down complex endocrine concepts. Comprehensive Legal & Medical Disclaimer: Endocrine Deep Dives and all associated content, materials, and digital assets are produced strictly for informational and educational purposes only. The program is intended solely for healthcare providers, medical fellows, residents, and students as a supplement to their professional training. No Physician-Patient Relationship: Listening to this podcast, accessing show notes, or interacting with the platform does not establish a physician-patient, pharmacist-patient, or any other formal professional-client relationship between the host and any listener or patient. Not Medical Advice: The content does not constitute individualized medical advice, clinical diagnosis, or treatment recommendations. Patients and members of the general public must never use this content to guide personal healthcare decisions and must always consult a qualified, licensed physician or healthcare provider for any medical concerns. Clinical Responsibility: Healthcare professionals listening to this program must exercise their own independent clinical judgment. The host's interpretations, study notes, and opinions reflect personal perspectives on literature and do not set an official standard of care. Clinicians bear sole responsibility for verifying all pharmacological dosing, diagnostic criteria, and treatment protocols against official institutional guidelines, current primary literature, and individual patient presentation. Limitation of Liability: The host, creators, and associated entities disclaim any and all liability for direct, indirect, incidental, or consequential damages resulting from the use, misuse, application, or interpretation of any information presented in this podcast. Reliance on any data or opinion provided is solely at the listener's own risk.